Nov 14, 2022 7:05am EST Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update
Nov 03, 2022 7:05am EDT Virios Therapeutics to Report Third Quarter 2022 Financial Results and Provide Corporate Update on Monday, November 14, 2022
Sep 19, 2022 7:05am EDT Virios Therapeutics Announces Top-Line Results from Phase 2b Study of IMC-1 in Fibromyalgia
Aug 15, 2022 7:05am EDT Virios Therapeutics’ Announces Dosing of First Patient in IMC-2 Long-COVID Treatment Trial
Aug 11, 2022 7:05am EDT Virios Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
Aug 10, 2022 4:01pm EDT Virios Therapeutics, Inc. to Present at Investor Summit Group’s Q3 Virtual Conference
